A novel duodenal mucosal resurfacing (DMR) ablation procedure improves glycaemic control and allows many people with type 2 diabetes to discontinue insulin, according to findings presented at UEG 2020. Researchers from the Netherland showed that the procedure which rejuvenates the lining of the duodenum to be highly effective when combined with glucagon-like peptide 1 (GLP-1) ...
Type 2 diabetes
Duodenal mucosal resurfacing allows T2D patients to stop insulin
By Michael Woodhead
15 Oct 2020